BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Otręba M, Kośmider L, Rzepecka-Stojko A. Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review. Eur J Pharmacol 2020;887:173553. [PMID: 32949606 DOI: 10.1016/j.ejphar.2020.173553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Eugene AR, Eugene B, Masiak M, Masiak JS. Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020. Front Pharmacol 2021;12:621691. [PMID: 33841149 DOI: 10.3389/fphar.2021.621691] [Reference Citation Analysis]
2 Yuan W, Dong X, Chen L, Lei X, Zhou Z, Guo L, Wang J. Screening for inhibitors against SARS-CoV-2 and its variants. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.05.002] [Reference Citation Analysis]
3 Mueller JK, Riederer P, Müller WE. Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence? Pharmacopsychiatry 2022;55:7-15. [DOI: 10.1055/a-1717-2381] [Reference Citation Analysis]
4 Otręba M, Sjölander JJ, Grøtli M, Sunnerhagen P. A Small Molecule Targeting Human MEK1/2 Enhances ERK and p38 Phosphorylation under Oxidative Stress or with Phenothiazines. Life (Basel) 2021;11:297. [PMID: 33807495 DOI: 10.3390/life11040297] [Reference Citation Analysis]
5 Chen F, Shi Q, Pei F, Vogt A, Porritt RA, Garcia G Jr, Gomez AC, Cheng MH, Schurdak ME, Liu B, Chan SY, Arumugaswami V, Stern AM, Taylor DL, Arditi M, Bahar I. A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. Mol Syst Biol 2021;17:e10239. [PMID: 34339582 DOI: 10.15252/msb.202110239] [Reference Citation Analysis]
6 Lucchetta M, Pellegrini M. Drug repositioning by merging active subnetworks validated in cancer and COVID-19. Sci Rep 2021;11:19839. [PMID: 34615934 DOI: 10.1038/s41598-021-99399-2] [Reference Citation Analysis]
7 Empel A, Bak A, Kozik V, Latocha M, Cizek A, Jampilek J, Suwinska K, Sochanik A, Zieba A. Towards Property Profiling: SYNTHESIS and SAR Probing of New Tetracyclic Diazaphenothiazine Analogues. Int J Mol Sci 2021;22:12826. [PMID: 34884631 DOI: 10.3390/ijms222312826] [Reference Citation Analysis]
8 Golden SR, Rosenstein DL, Belhorn T, Blatt J. Repurposing Psychotropic Agents for Viral Disorders: Beyond Covid. Assay Drug Dev Technol 2021. [PMID: 34375133 DOI: 10.1089/adt.2021.014] [Reference Citation Analysis]
9 Sadeghian I, Heidari R, Sadeghian S, Raee MJ, Negahdaripour M. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. Eur J Pharm Sci 2021;169:106094. [PMID: 34896590 DOI: 10.1016/j.ejps.2021.106094] [Reference Citation Analysis]
10 Kulkarni R, Wiemer EAC, Chang W. Role of Lipid Rafts in Pathogen-Host Interaction - A Mini Review. Front Immunol 2022;12:815020. [DOI: 10.3389/fimmu.2021.815020] [Reference Citation Analysis]
11 Sibilio P, Bini S, Fiscon G, Sponziello M, Conte F, Pecce V, Durante C, Paci P, Falcone R, Norata GD, Farina L, Verrienti A. In silico drug repurposing in COVID-19: A network-based analysis. Biomed Pharmacother 2021;142:111954. [PMID: 34358753 DOI: 10.1016/j.biopha.2021.111954] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Villoutreix BO, Krishnamoorthy R, Tamouza R, Leboyer M, Beaune P. Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities. Adv Appl Bioinform Chem 2021;14:71-85. [PMID: 33880039 DOI: 10.2147/AABC.S304649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Booz GW, Zouein FA. Science unites a troubled world: Lessons from the pandemic. Eur J Pharmacol 2021;890:173696. [PMID: 33130278 DOI: 10.1016/j.ejphar.2020.173696] [Reference Citation Analysis]
14 Javelot H, Straczek C, Meyer G, Gitahy Falcao Faria C, Weiner L, Drapier D, Fakra E, Fossati P, Weibel S, Dizet S, Langrée B, Masson M, Gaillard R, Leboyer M, Llorca PM, Hingray C, Haffen E, Yrondi A. Psychotropics and COVID-19: An analysis of safety and prophylaxis. Encephale 2021;47:564-88. [PMID: 34548153 DOI: 10.1016/j.encep.2021.08.002] [Reference Citation Analysis]
15 Posso MC, Domingues FC, Ferreira S, Silvestre S. Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review. Molecules 2022;27:276. [PMID: 35011508 DOI: 10.3390/molecules27010276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]